Evaluation of the part-d enhanced medication therapy management model

Ended Awarded Last action

Contract number
HHSM500T0005
Awardee
Awarding agency
Obligated
$14,074,234

Award facts

Contract value 100% obligated
$14,074,233.82 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Windsor Mill, Milford Mill, MD 21244, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$191,411
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 $0
Exercise an Option P00002 $6,642,137
Other Administrative Action P00001 $0
Other Administrative Action 1 $0
Original award $7,623,508

About this award

The Centers for Medicare and Medicaid Services (CMS) awarded a cost-plus-fixed-fee delivery order to Acumen LLC (doing business as Medric) on September 20, 2016, for the evaluation of the Part D Enhanced Medication Therapy Management Model. The contract, valued at $14.07 million with a completion date of February 19, 2023, was issued under the Research Measurement Assessment Design and Analysis (RMADA) master Indefinite Delivery Indefinite Quantity (IDIQ) contract. The award carries no set-aside designation, indicating it was competed among all eligible contractors. Work will be performed at locations in Windsor Mill and Milford Mill, Maryland.

Acumen LLC, a California-based healthcare data analytics and research firm, brings substantial expertise in supporting federal health agencies through complex data modeling, analysis, and program evaluation services. The contractor specializes in leveraging advanced healthcare data analytics to inform policy development and program assessment—core capabilities directly applicable to evaluating medication therapy management initiatives under Medicare Part D. The evaluation work aligns with CMS's broader efforts to assess the effectiveness of medication management programs for Medicare beneficiaries and contribute evidence to policy decision-making within the agency's prescription drug benefit programs.

Quick answers

Who was awarded contract HHSM500T0005?

HHSM500T0005 was awarded to Acumen LLC by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on September 20, 2016.

How much is contract HHSM500T0005 worth?

The government has obligated $14,074,234 on HHSM500T0005.

Is contract HHSM500T0005 an order under another contract?

Yes. HHSM500T0005 is a delivery order under HHSM500201400027I, an indefinite delivery contract, on Research Measurement Assessment Design and Analysis (RMADA).

Was contract HHSM500T0005 competed?

The extent of competition for HHSM500T0005 was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award